These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 34135034)

  • 1. Pharmacogenetics to Avoid Loss of Hearing (PALOH) trial: a protocol for a prospective observational implementation trial.
    McDermott JH; Mahood R; Stoddard D; Mahaveer A; Turner MA; Corry R; Garlick J; Miele G; Ainsworth S; Kemp L; Bruce I; Body R; Ulph F; Macleod R; Harvey K; Booth N; Roberts P; Wilson P; Newman WG
    BMJ Open; 2021 Jun; 11(6):e044457. PubMed ID: 34135034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid Point-of-Care Genotyping to Avoid Aminoglycoside-Induced Ototoxicity in Neonatal Intensive Care.
    McDermott JH; Mahaveer A; James RA; Booth N; Turner M; Harvey KE; Miele G; Beaman GM; Stoddard DC; Tricker K; Corry RJ; Garlick J; Ainsworth S; Beevers T; Bruce IA; Body R; Ulph F; MacLeod R; Roberts PL; Wilson PM; Newman WG;
    JAMA Pediatr; 2022 May; 176(5):486-492. PubMed ID: 35311942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic testing in the acute setting: a round table discussion.
    McDermott JH
    J Med Ethics; 2020 Aug; 46(8):531-532. PubMed ID: 32651253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Terrible choices in the septic child: a response to the PALOH trial round table authors.
    Parker J; Wright D
    J Med Ethics; 2021 Feb; 47(2):114-116. PubMed ID: 33208480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gentamicin, genetic variation and deafness in preterm children.
    Bitner-Glindzicz M; Rahman S; Chant K; Marlow N
    BMC Pediatr; 2014 Mar; 14():66. PubMed ID: 24593698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is deafness mutation screening required in cystic fibrosis patients?
    Abusamra R; McShane D
    Paediatr Respir Rev; 2016 Aug; 20 Suppl():24-6. PubMed ID: 27427311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hearing in 44-45 year olds with m.1555A>G, a genetic mutation predisposing to aminoglycoside-induced deafness: a population based cohort study.
    Rahman S; Ecob R; Costello H; Sweeney MG; Duncan AJ; Pearce K; Strachan D; Forge A; Davis A; Bitner-Glindzicz M
    BMJ Open; 2012; 2(1):e000411. PubMed ID: 22223843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein point-of-care testing for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease: the PACE RCT.
    Francis NA; Gillespie D; White P; Bates J; Lowe R; Sewell B; Phillips R; Stanton H; Kirby N; Wootton M; Thomas-Jones E; Hood K; Llor C; Cals J; Melbye H; Naik G; Gal M; Fitzsimmons D; Alam MF; Riga E; Cochrane A; Butler CC
    Health Technol Assess; 2020 Mar; 24(15):1-108. PubMed ID: 32202490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal hearing in a child with the m.1555A>G mutation despite repeated exposure to aminoglycosides. Has the penetrance of this pharmacogenetic interaction been overestimated?
    Al-Malky G; Suri R; Sirimanna T; Dawson SJ
    Int J Pediatr Otorhinolaryngol; 2014 Jun; 78(6):969-73. PubMed ID: 24703164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pragmatic multicentre randomised controlled trial evaluating the impact of a routine molecular point-of-care 'test-and-treat' strategy for influenza in adults hospitalised with acute respiratory illness (FluPOC): trial protocol.
    Beard K; Brendish N; Malachira A; Mills S; Chan C; Poole S; Clark T
    BMJ Open; 2019 Dec; 9(12):e031674. PubMed ID: 31852699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial mutation m.1555A>G as a risk factor for failed newborn hearing screening in a large cohort of preterm infants.
    Göpel W; Berkowski S; Preuss M; Ziegler A; Küster H; Felderhoff-Müser U; Gortner L; Mögel M; Härtel C; Herting E;
    BMC Pediatr; 2014 Aug; 14():210. PubMed ID: 25155176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel electronic algorithm using host biomarker point-of-care tests for the management of febrile illnesses in Tanzanian children (e-POCT): A randomized, controlled non-inferiority trial.
    Keitel K; Kagoro F; Samaka J; Masimba J; Said Z; Temba H; Mlaganile T; Sangu W; Rambaud-Althaus C; Gervaix A; Genton B; D'Acremont V
    PLoS Med; 2017 Oct; 14(10):e1002411. PubMed ID: 29059253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extended-interval aminoglycoside administration for children: a meta-analysis.
    Contopoulos-Ioannidis DG; Giotis ND; Baliatsa DV; Ioannidis JP
    Pediatrics; 2004 Jul; 114(1):e111-8. PubMed ID: 15231982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial.
    Bates J; Francis NA; White P; Gillespie D; Thomas-Jones E; Breen R; Kirby N; Hood K; Gal M; Phillips R; Naik G; Cals J; Llor C; Melbye H; Wootton M; Riga E; Cochrane A; Howe R; Fitzsimmons D; Sewell B; Alam MF; Butler CC
    Trials; 2017 Sep; 18(1):442. PubMed ID: 28969667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotic prescribing rate after optimal near-patient C-reactive protein testing in acutely ill children presenting to ambulatory care (ARON project): protocol for a cluster-randomized pragmatic trial.
    Verbakel JYJ; De Burghgraeve T; Van den Bruel A; Coenen S; Anthierens S; Joly L; Laenen A; Luyten J; De Sutter A
    BMJ Open; 2022 Jan; 12(1):e058912. PubMed ID: 34980633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent Hearing and Genetic Screening of 180,469 Neonates with Follow-up in Beijing, China.
    Dai P; Huang LH; Wang GJ; Gao X; Qu CY; Chen XW; Ma FR; Zhang J; Xing WL; Xi SY; Ma BR; Pan Y; Cheng XH; Duan H; Yuan YY; Zhao LP; Chang L; Gao RZ; Liu HH; Zhang W; Huang SS; Kang DY; Liang W; Zhang K; Jiang H; Guo YL; Zhou Y; Zhang WX; Lyu F; Jin YN; Zhou Z; Lu HL; Zhang X; Liu P; Ke J; Hao JS; Huang HM; Jiang D; Ni X; Long M; Zhang L; Qiao J; Morton CC; Liu XZ; Cheng J; Han DM
    Am J Hum Genet; 2019 Oct; 105(4):803-812. PubMed ID: 31564438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rapid intrapartum test for group B Streptococcus to reduce antibiotic usage in mothers with risk factors: the GBS2 cluster RCT.
    Daniels J; Dixon EF; Gill A; Bishop J; D'Amico M; Ahmed K; Dodds J; Tryposkiadis K; Wilks M; Millar M; Husain S; Gray J; Whiley A; Moore PV; Munetsi RL; Hemming K; Roberts T; Plumb J; Deeks J; Khan KS; Thangaratinam S
    Health Technol Assess; 2022 Feb; 26(12):1-82. PubMed ID: 35195519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial haplotypes may modulate the phenotypic manifestation of the deafness-associated 12S rRNA 1555A>G mutation.
    Lu J; Qian Y; Li Z; Yang A; Zhu Y; Li R; Yang L; Tang X; Chen B; Ding Y; Li Y; You J; Zheng J; Tao Z; Zhao F; Wang J; Sun D; Zhao J; Meng Y; Guan MX
    Mitochondrion; 2010 Jan; 10(1):69-81. PubMed ID: 19818876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.